US 6,984,504 B2Granted

Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons

AssigneeThe United States of America as represented by the Secretary of the Army

InventorsMary K. Hart, Julie A. Wilson, Peter Pushko, Jonathan F. Smith, Alan L. Schmaljohn

Life of this patent

Estimating the term…

Abstract

Using the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described.

Claims4

Dependent claims

The recombinant DNA construct designated VRepEboVP35, having ATCC® accession number PTA-5649.

Dependencies are inferred from the claim text.

Facts

Application: 10/696,633Filed 29 Oct 2003 · continuation
Priority: 29 Jun 1998
Published: US 2004/0146859 A129 Jul 2004
Granted: 10 Jan 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
C07K 16/10
Against material from viruses: rNA viruses
C12N 7/00
Viruses
C12N 15/86
For animal cells: viral vectors

Family

Application60/091,403Us provisional application · filed 29 Jun 1998
Application09/337,946Parent of this continuation · filed 22 Jun 1999
US 2004/0146859 A1Pre-grant publication · published 29 Jul 2004
US 2002/0164582 A1Published application
US 6,984,504 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results